Wednesday, July 8, 2026

pharma · Advanced Solid Tumor · Hepatocellular Carcinoma

Coherus Oncology

Coherus Oncology clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065, US HQ
2010 Founded
212 Employees
NMPA registrant Type
Company details
Status
Public
HQ
333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065, US
Founded
2010
Employees
212
Programs
25
Drugs
11
Patents
73
Intelligence · Clinical Programs

Coherus Oncology projects

1 ClinicalTrials.gov programs sponsored by Coherus Oncology.

Coherus Oncology has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Toripalimab

    Coherus Oncology

    Nasopharyngeal Cancer Recurrent

    approved small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Coherus Oncology have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.